Rote William E.'s Form 4 filing
Travere Therapeutics, Inc. (TVTX) · filed Aug 17, 2021
- Accession no.
- 0001209191-21-052081
- Filed
- Aug 17, 2021
- Trade date
- Aug 13-17, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $24.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rote William E.CIK 0001698262 | Officer (Senior Vice President, R&D) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2021 | Common Stock | AGrant or awardAcquired | +4,500 | $0.00 | $0 | 37,138 | Direct | |
| Aug 17, 2021 | Common Stock | SSaleDisposed | −1,407 | $17.12 | −$24,087.84 | 35,731 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.